No Data
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
Pak Fah Yeow Announces Registrar Change in Hong Kong
Be Sure To Check Out Pak Fah Yeow International Limited (HKG:239) Before It Goes Ex-Dividend
PAK FAH YEOW: Interim Report 2024
Pak Fah Yeow Declares Special Interim Dividend
Pak Fah Yeow Declares Interim Dividend
